Brind.

Zacks Investment Research published stock analysis reports concerning Haemonetics on August 7, 2025.

1 report, 1 independent Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Zacks Investment Research published stock analysis reports concerning Haemonetics on August 7, 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Haemonetics

    company based in Braintree, Massachusetts, USA

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • ZacksHaemonetics (HAE) Reports Q1 Earnings: What Key Metrics Have to Say Haemonetics (HAE) reported $321.39 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 4.4